Covidien Income Statement
View: Annual
| Sep 08 | Sep 07 | Sep 06 | |
|---|---|---|---|
| Revenue | 9,910.0 | 10,170.0 | 9,647.0 |
| Cost of Goods Sold | 4,601.0 | 5,333.0 | 5,161.0 |
| Gross Profit | 5,309.0 | 4,837.0 | 4,486.0 |
| Gross Profit Margin | 53.6% | 47.6% | 46.5% |
| SG&A Expense | 2,881.0 | 2,537.0 | 2,081.0 |
| Depreciation & Amortization | 398.0 | 699.0 | 333.0 |
| Operating Income | 2,188.0 | 339.0 | 2,006.0 |
| Operating Margin | 22.1% | 3.3% | 20.8% |
| Nonoperating Income | 199.0 | (135.0) | 15.0 |
| Nonoperating Expenses | (166.0) | -- | -- |
| Income Before Taxes | 1,979.0 | 151.0 | 1,974.0 |
| Income Taxes | 536.0 | 488.0 | 504.0 |
| Net Income After Taxes | 1,443.0 | (337.0) | 1,470.0 |
| Continuing Operations | 1,443.0 | (337.0) | 1,470.0 |
| Discontinued Operations | (82.0) | (5.0) | (315.0) |
| Total Operations | 1,361.0 | (342.0) | 1,155.0 |
| Total Net Income | 1,361.0 | (342.0) | 1,155.0 |
| Net Profit Margin | 13.7% | -- | 12.0% |
| Diluted EPS from Total Net Income ($) | 2.70 | (0.69) | -- |
| Dividends per Share | 0.64 | 0.16 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
